Stay updated with breaking news from Derek Maetzold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript May 4, 2024 Castle Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Castle Biosciences First Quarter 2024 Conference Call. As a remainder, today’s call […]
Q1 2024 revenue increased 74% over Q1 2023 to $73 million Q1 2024 total test reports increased 40% over Q1 2023 Raising full-year 2024 revenue guidance to $255-265 million from $235-240...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that, for the second year in a row, its chief financial officer, Frank Stokes,...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that Rodney Cotton has been appointed to its board of directors, effective...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Mar 27, 2024--